drugset / Trial / NCT00689637

Drug Interaction Study Between AZD3480 and Warfarin

NCT00689637

Phase 1 Completed 26 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of the study is to evaluate if AZD3480 and warfarin interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administered alone.

Timeline

Start
2007-09
Primary completion
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule
Subject ispronicline Small molecule

Indications